Larsen F F, Pryor G T
Pharmacol Biochem Behav. 1977 Oct;7(4):323-9. doi: 10.1016/0091-3057(77)90228-3.
Male, Fischer strain rats were resistant to the impairing effects of delta9--THC (15-60 mg/kg, IG) on performance of a conditioned pole-climb avoidance response (CAR) after daily subacute pretreatment for 4 or 6 days. A single administration of 20 mg/kg delta9--THC independent of the performance test did not attenuate the subsequent impairment caused by delta9--THC when tested 1-6 days later; however, administration 2 hr before each test attenuated the effect on subsequent tests given at intervals of 1-5 weeks. Similarly, subacute treatment with 20 mg/kg delta9--THC for 4 days independent of the performance test attenuated the impairment caused by delta9--THC during tests given to separate groups of rats 1 or 6, but not 14 days later. However, when the tests for tolerance were conducted repeatedly in the same rats, the attenuation appeared to persist for intervals up to 5 weeks. The results are discussed in terms of metabolic, functional and compensatory (behavioral) tolerance.
雄性Fischer品系大鼠在每天进行4或6天的亚急性预处理后,对δ9 - 四氢大麻酚(15 - 60毫克/千克,灌胃)对条件性爬杆回避反应(CAR)表现的损害作用具有抗性。无论性能测试如何,单次给予20毫克/千克的δ9 - 四氢大麻酚,在1 - 6天后进行测试时,并不会减轻随后由δ9 - 四氢大麻酚引起的损害;然而,在每次测试前2小时给药可减轻对1 - 5周间隔进行的后续测试的影响。同样,无论性能测试如何,用20毫克/千克的δ9 - 四氢大麻酚进行4天的亚急性治疗可减轻在1天或6天后对不同组大鼠进行测试时由δ9 - 四氢大麻酚引起的损害,但在14天后则不会。然而,当在同一只大鼠中反复进行耐受性测试时,这种减轻作用似乎可持续长达5周的时间。将根据代谢、功能和代偿性(行为)耐受性来讨论这些结果。